[go: up one dir, main page]

WO2008118785A3 - Procédés de traitement de la dépression utilisant des traitements à effet immédiat et la d-cyclosérine - Google Patents

Procédés de traitement de la dépression utilisant des traitements à effet immédiat et la d-cyclosérine Download PDF

Info

Publication number
WO2008118785A3
WO2008118785A3 PCT/US2008/057844 US2008057844W WO2008118785A3 WO 2008118785 A3 WO2008118785 A3 WO 2008118785A3 US 2008057844 W US2008057844 W US 2008057844W WO 2008118785 A3 WO2008118785 A3 WO 2008118785A3
Authority
WO
WIPO (PCT)
Prior art keywords
immediate
methods
cycloserine
impact
treating depression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/057844
Other languages
English (en)
Other versions
WO2008118785A2 (fr
Inventor
Jason P Mcdevitt
Michael Davis
Kerry J Ressler
Nathan Andrew Shapira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TIKVAH THERAPEUTICS
Original Assignee
TIKVAH THERAPEUTICS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TIKVAH THERAPEUTICS filed Critical TIKVAH THERAPEUTICS
Publication of WO2008118785A2 publication Critical patent/WO2008118785A2/fr
Publication of WO2008118785A3 publication Critical patent/WO2008118785A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne des procédés de traitement de la dépression chez l'homme. Les procédés comprennent l'administration de D-cyclosérine à un sujet et l'administration d'un traitement pour la dépression à effet immédiat. Des exemples de traitements à effet immédiat pour la dépression comprennent l'administration de kétamine, ainsi que des traitements non pharmacologiques tels que le traitement convulsivant à l'électrochoc.
PCT/US2008/057844 2007-03-23 2008-03-21 Procédés de traitement de la dépression utilisant des traitements à effet immédiat et la d-cyclosérine Ceased WO2008118785A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89655607P 2007-03-23 2007-03-23
US60/896,556 2007-03-23

Publications (2)

Publication Number Publication Date
WO2008118785A2 WO2008118785A2 (fr) 2008-10-02
WO2008118785A3 true WO2008118785A3 (fr) 2008-12-24

Family

ID=39789245

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/057844 Ceased WO2008118785A2 (fr) 2007-03-23 2008-03-21 Procédés de traitement de la dépression utilisant des traitements à effet immédiat et la d-cyclosérine

Country Status (1)

Country Link
WO (1) WO2008118785A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11974551B2 (en) 2011-11-21 2024-05-07 The Institute For Ethnomedicine L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2538939A1 (fr) * 2010-02-24 2013-01-02 Universität Zürich Prévention et traitement de maladies provoquées par des niveaux élevés de désoxysphingolipides
AU2014250756B2 (en) 2013-04-12 2019-03-07 Icahn School Of Medicine At Mount Sinai Method for treating post-traumatic stress disorder
EP3960162A1 (fr) * 2013-08-26 2022-03-02 Amorsa Therapeutics, Inc. Dose orale à couche unique de kétamine neuro-atténuante
EP3377050A4 (fr) 2015-11-17 2019-11-20 The Trustees of Columbia University in the City of New York Agents prophylactiques pharmacologiques contre des troubles affectifs induits par le stress et leurs symptômes associés
CN105476976B (zh) * 2015-12-22 2018-09-25 广州瑞尔医药科技有限公司 药物组合物及其制备方法和应用
WO2019094757A1 (fr) 2017-11-09 2019-05-16 The Trustees Of Columbia University In The City Of New York Agents prophylactiques pharmacologiques contre des troubles affectifs induits par le stress chez les femelles
WO2019094596A1 (fr) 2017-11-09 2019-05-16 The Trustees Of Columbia University In The City Of New York Biomarqueurs pour l'efficacité de traitements prophylactiques contre des troubles affectifs induits par le stress
MX2022006342A (es) * 2019-11-27 2022-08-11 Neurorive Inc Terapia combinada de cicloserina y litio para el tratamiento de la depresion.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999052519A2 (fr) * 1998-04-14 1999-10-21 The General Hospital Corporation Methodes de traitement de troubles neuropsychiatriques
US20050222270A1 (en) * 2004-02-26 2005-10-06 Olney John W Prolonged administration of NMDA antagonist drug and safener drug to create improved stable neural homeostasis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999052519A2 (fr) * 1998-04-14 1999-10-21 The General Hospital Corporation Methodes de traitement de troubles neuropsychiatriques
US20050222270A1 (en) * 2004-02-26 2005-10-06 Olney John W Prolonged administration of NMDA antagonist drug and safener drug to create improved stable neural homeostasis

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ARCHIVES OF GENERAL PSYCHIATRY, vol. 63, no. 8, August 2006 (2006-08-01), pages 856 - 864, ISSN: 0003-990X *
BIOLOGICAL PSYCHIATRY, vol. 47, no. 4, 15 February 2000 (2000-02-15), pages 351 - 354, ISSN: 0006-3223 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 15 February 2000 (2000-02-15), BERMAN ROBERT M ET AL: "Antidepressant effects of ketamine in depressed patients", XP002501675, Database accession no. PREV200000162237 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; August 2006 (2006-08-01), ZARATE CARLOS A JR ET AL: "A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression", XP002501674, Database accession no. PREV200600586874 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11974551B2 (en) 2011-11-21 2024-05-07 The Institute For Ethnomedicine L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders

Also Published As

Publication number Publication date
WO2008118785A2 (fr) 2008-10-02

Similar Documents

Publication Publication Date Title
WO2008118785A3 (fr) Procédés de traitement de la dépression utilisant des traitements à effet immédiat et la d-cyclosérine
WO2008122049A3 (fr) Procédés et compositions pour la réduction des effets secondaires des traitements thérapeutiques
WO2007146411A3 (fr) Thérapie basée sur des nanoparticules
WO2008054585A3 (fr) Utilisation d'il-10 pégilée pour traiter un cancer
WO2012002760A3 (fr) Méthode de diagnostic et de traitement du cancer par des microvésicules cellulaires
WO2012062925A3 (fr) Composés et procédés de traitement de la douleur
WO2009023509A3 (fr) Combinaisons thérapeutiques utiles pour traiter les maladies liées au cftr
KZ24152B (en) Method of photosensitizer activation, treatment method with application of activated photosensitizer and photosensitizer application to prepare medicine
GB2442915B (en) Perylenequinone derivatives and uses thereof
WO2009155439A3 (fr) Utilisation de lipides nitrés pour le traitement d'effets secondaires de thérapies médicales toxiques
WO2007081879A3 (fr) Méthodes pour prévenir et traiter des métastases de cancer et des pertes osseuses associées à des métastases de cancer
WO2010014595A3 (fr) Méthodes et compositions d'administration d'agents thérapeutiques dans le traitement de troubles associés aux lymphocytes b
WO2010032011A3 (fr) Thérapie antifongique
WO2008054711A3 (fr) Inhibiteur de télomérase combiné à la gemcitabine dans le traitement du cancer
WO2005089504A3 (fr) Procedes pour le traitement de synucleinopathies
WO2010037864A3 (fr) Inhibition du plgf pour traiter les leucémies à chromosome positif philadelphia
WO2008033440A3 (fr) Traitement de maladies hyperprolifératives à l'aide d'anthraquinones
WO2007106884A3 (fr) Méthodes de traitement des maladies d'atrophie musculaire au moyen d'inhibiteurs de l'activation de nf-kb
WO2008045378A3 (fr) Traitement d'hyperbilirubinémie infantile en utilisant des faibles dosages de stannsoporfine
WO2005089515A3 (fr) Procedes de traitement des synucleinopathies
WO2007134203A3 (fr) Traitements anticancéreux
WO2007130501A3 (fr) Polythérapie pour traiter le cancer
WO2010019717A3 (fr) Thérapie de combinaison d'inhibiteurs de fusion/entrée du vih ciblant gp41
SG10201408374WA (en) Therapeutic Combinations Of Theobromine And An Antihistamine
WO2008039994A3 (fr) Agent thérapeutique photodynamique ciblé

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08732664

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 08732664

Country of ref document: EP

Kind code of ref document: A2